CD33 and Alzheimer disease: Next, we investigated whether the interactions of CRP levels with SPI1 and CD33 polymorphisms, which were associated with AD risk in the UKBB and FHS datasets, were also associated with the conversion of MCI to AD and AD-related CSF biomarkers in ADNI participants.